A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia

Clinical trial NCT02255435 · COMPLETED

Trial details

NCT number: NCT02255435
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Friedreich Ataxia

Start date: 2015-01-31
Primary completion: 2019-10-31
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.